查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1596646

空間基因組學和轉錄組學市場：按產品、技術和最終用戶分類 - 2025-2030 年全球預測

Spatial Genomics & Transcriptomics Market by Product (Consumables, Instruments, Software), Technology (Immunohistochemistry Screening, Spatial Genomics, Spatial Transcriptomics), End-Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年空間基因組學和轉錄組學市場價值為78233萬美元，預計2024年將達到87903萬美元，複合年成長率為13.62%，到2030年將達到191312萬美元，預計將達到1000萬美元。

空間基因組學和轉錄組學是關注組織內基因的空間組織和表達的前沿領域。這些領域的需求源自於傳統基因組技術的局限性，這些技術往往忽略基因表現的空間背景，從而錯過對細胞功能、疾病進展和組織結構的重要見解。其應用範圍從癌症研究和神經科學到發育生物學和個人化醫學，其中了解基因活動的空間排列可以為標靶治療和介入提供資訊。典型的最終用戶包括專注於藥物發現和開發的學術研究機構、生技公司和製藥公司。

主要市場統計
基準年[2023] 78233萬美元
預測年份 [2024] 8.7903億美元
預測年份 [2030] 1,913,120,000 美元
複合年成長率（%） 13.62%

市場洞察強調，在技術進步和定序成本下降的推動下，對高解析度空間成像和全面分子分析的需求不斷成長正在推動成長。此外，人工智慧和機器學習在資料分析中的集合成為從複雜的空間資料中提取有意義的見解提供了新的維度。然而，挑戰包括資料複雜性、高解析度成像技術的高成本以及對高技能專家的需求等技術限制。有關基因組學資料隱私的監管障礙和道德考慮也是限制因素。

有潛在機會開發更具成本效益和易於使用的技術，改進資料整合方法，並增強易於使用的分析軟體。工業界和學術界之間加強合作將刺激創新，研發投資將帶來多重功能和單細胞分析技術的突破。由於商業性利益的增加和旨在擴大產品系列的策略聯盟，市場正在迅速發展。最佳創新領域包括用於資料可視化的生物資訊軟體、整合多組體學資料的平台以及新穎的單細胞空間分析。這個充滿活力的市場必須不斷適應技術進步和不斷變化的監管環境，而徹底的市場分析對於持續成長和競爭力至關重要。

市場動態：揭示快速發展的空間基因組學和轉錄組學市場的關鍵市場洞察

供需的動態交互作用正在改變空間基因組學和轉錄組學市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 慢性病流行以及準確有效的藥物設計的必要性
    • 提高基因組學和定序技術的監管和道德接受度
    • 更多地使用空間分析來推進精準醫學和診斷
  • 市場限制因素
    • 新興經濟體醫療保健專業人員對基因組醫學的認知較低
  • 市場機會
    • 太空生物學的技術進步主要集中在人工智慧、3D 列印和標準化診斷生物標記上
    • 增加基因組學和轉錄組學研究的公共和私人資助
  • 市場挑戰
    • 基因和單細胞定序的報銷差異和不確定性

波特五力：駕馭空間基因體學與轉錄組學市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解空間基因組學和轉錄組學市場的外部影響

外部宏觀環境因素在塑造空間基因組學和轉錄組學市場的績效動態方面發揮關鍵作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解空間基因體學和轉錄組學市場的競爭格局

空間基因組學和轉錄組學市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣空間基因組學和轉錄組學市場供應商的績效評估

FPNV 定位矩陣是評估空間基因組學和轉錄組學市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議繪製空間基因組學和轉錄組學市場的成功之路

空間基因組學和轉錄組學市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5.產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 慢性病的流行和開發精準有效藥物的必要性
      • 改善基因組學和定序技術的監管和道德接受度
      • 空間分析的新用途推進精準醫學和診斷
    • 抑制因素
      • 新興經濟體的醫療保健專業人員對基因組醫學的認知有限
    • 機會
      • 太空生物學的技術進步主要集中在人工智慧、3D列印和標準化診斷生物標記。
      • 增加基因組學和轉錄組學研究的公共和私人資助
    • 任務
      • 基因和單細胞定序的報銷差異和不確定性
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章空間基因組學和轉錄組學市場：依產品

  • 消耗品
  • 裝置
  • 軟體

第7章 空間基因體學與轉錄組學市場：依技術分類

  • 免疫組織化學篩檢
  • 空間基因體學
    • 生化技術
    • 螢光原位雜合反應
    • 基因組擾動工具
    • 大規模平行定定序
    • 使用顯微鏡進行生物 DNA 成像
  • 空間轉錄組學
    • 原位定序
    • 切片順序
    • 基於序列的方法
    • 體內轉錄組分析

第8章空間基因組學和轉錄組學市場：按最終用途

  • 學術機構
  • 診斷機構
  • 藥品製造商
  • 轉化研究

第9章美洲空間基因組學和轉錄組學市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區空間基因體學與轉錄組學市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲的空間基因組學和轉錄組學市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • OmicsVeu 推出廣泛的空間生物學產品線
    • Bio-Rad 在 AGBT 2022 上推出 SEQuoia Express 鏈 RNA 文庫製備試劑套件
    • Lexogen 推出 CORALL RNA-Seq V2，這是一種快速、靈活的全轉錄組 RNA-Seq 文庫製備試劑套件。
    • NanoString發布新的nCounter Pro分析系統
    • Singular Genomics 與 QIAGEN 合作，為 G4定序平台提供 QIAseq 試劑套件
    • Fulgent Genetics 宣布對空間基因組學進行策略性投資
    • Singular Genomics 與 Lexogen 合作，為 G4定序平台實現 RNA 文庫製備
    • Bio-Techne 和 Akoya Biosciences 合作，以業界領先的速度和解析度實現自動化空間多組體學工作流程
    • Andor 和 Akoya Biosciences 合作進軍太空體學市場
  • 戰略分析和建議

公司名單

  • 10X Genomics, Inc.
  • Akoya Biosciences, Inc.
  • Arima Genomics, Inc.
  • AtlasXomics Inc.
  • Axcelead Drug Discovery Partners Inc.
  • BGI Australia
  • Bio-Techne Corporation
  • BioSpyder Technologies Inc.
  • Bruker Corporation
  • Bucher Biotec AG
  • CD Genomics
  • CeGaT GmbH
  • Dovetail Genomics, LLC
  • Easi-Genomics
  • Enzo Life Sciences, Inc.
  • Eurofins Genomics
  • Fulgent Genetics
  • Genomic Vision SA
  • Illumina, Inc.
  • Indivumed Group
  • Ionpath, Inc.
  • Lunaphore Technologies SA
  • Miltenyi Biotec
  • Nanostring Technologies, Inc.
  • Natera Inc.
  • Novogene Co, Ltd.
  • Oxford Nanopore Technologies PLC
  • PerkinElmer, Inc.
  • PT Pandu Biosains
  • Rarecyte, Inc
  • Rebus Biosystems, Inc.
  • Resolve Biosciences GmbH
  • S2 Genomics, Inc.
  • Seven Bridges Genomics
  • Single Cell Discoveries
  • Single Technologies AB
  • Singular Genomics System, Inc.
  • Spatial Genomics
  • Springer Nature
  • Standard BioTools Inc.
  • Tecan Group Ltd.
  • Ultivue, Inc.
  • Veracyte, Inc.
  • Veranome Biosystems, LLC
  • Vizgen Corporation
Product Code: MRR-F611BFBC5D35

The Spatial Genomics & Transcriptomics Market was valued at USD 782.33 million in 2023, expected to reach USD 879.03 million in 2024, and is projected to grow at a CAGR of 13.62%, to USD 1,913.12 million by 2030.

Spatial genomics and transcriptomics represent cutting-edge fields that focus on the spatial organization and expression of genes within tissues. The necessity of these fields stems from the limitations of conventional genomic technologies, which often disregard the spatial context of gene expression, thus missing critical insights into cellular function, disease progression, and tissue architecture. Applications are vast, ranging from cancer research and neuroscience to developmental biology and personalized medicine, where understanding the spatial arrangement of gene activity can inform targeted therapies and interventions. Key end-users include academic research institutions, biotechnology companies, and pharmaceutical industries focusing on drug discovery and development.

KEY MARKET STATISTICS
Base Year [2023] USD 782.33 million
Estimated Year [2024] USD 879.03 million
Forecast Year [2030] USD 1,913.12 million
CAGR (%) 13.62%

Market insights highlight that the increasing demand for high-resolution spatial imaging and comprehensive molecular profiling is driving growth, fueled by technological advancements and decreasing sequencing costs. Additionally, the integration of artificial intelligence and machine learning in data analysis provides new dimensions for extracting meaningful insights from complex spatial data. However, challenges include technical constraints such as data complexity, high costs of high-resolution imaging technologies, and the need for highly skilled professionals. Regulatory hurdles and ethical considerations regarding data privacy in genomics also pose limitations.

Potential opportunities lie in developing more cost-effective and accessible technologies, improving data integration methods, and enhancing user-friendly analytical software. Increased collaboration between industry and academic sectors can spur innovation, while investment in R&D can lead to breakthroughs in multiplexing capabilities and single-cell analysis techniques. The market is rapidly evolving, underscored by increasing commercial interest and strategic partnerships aimed at expanding product portfolios. Best areas for innovation include bioinformatics software for data visualization, platforms for integrating multi-omics data, and novel single-cell spatial assays. This dynamic market requires continual adaptation to technological advancements and shifting regulatory landscapes, making thorough market analysis crucial for sustained growth and competitiveness.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Spatial Genomics & Transcriptomics Market

The Spatial Genomics & Transcriptomics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Prevalence of chronic diseases and need for designing accurate and effective drugs
    • Improving regulatory and ethical acceptance of genomics and sequencing technologies
    • Emerging use of spatial analysis to advance precision medicine & diagnostics
  • Market Restraints
    • Limited awareness among healthcare professionals about genomic medicine in developing economies
  • Market Opportunities
    • Technological advancements in spatial biology primarily focused on AI, 3D printing, and standardized diagnostic biomarkers
    • Rising public and private funding for genomics & transcriptomics research
  • Market Challenges
    • Reimbursement inconsistency and uncertainty in gene & single-cell sequencing

Porter's Five Forces: A Strategic Tool for Navigating the Spatial Genomics & Transcriptomics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Spatial Genomics & Transcriptomics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Spatial Genomics & Transcriptomics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Spatial Genomics & Transcriptomics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Spatial Genomics & Transcriptomics Market

A detailed market share analysis in the Spatial Genomics & Transcriptomics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Spatial Genomics & Transcriptomics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Spatial Genomics & Transcriptomics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Spatial Genomics & Transcriptomics Market

A strategic analysis of the Spatial Genomics & Transcriptomics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Spatial Genomics & Transcriptomics Market, highlighting leading vendors and their innovative profiles. These include 10X Genomics, Inc., Akoya Biosciences, Inc., Arima Genomics, Inc., AtlasXomics Inc., Axcelead Drug Discovery Partners Inc., BGI Australia, Bio-Techne Corporation, BioSpyder Technologies Inc., Bruker Corporation, Bucher Biotec AG, CD Genomics, CeGaT GmbH, Dovetail Genomics, LLC, Easi-Genomics, Enzo Life Sciences, Inc., Eurofins Genomics, Fulgent Genetics, Genomic Vision SA, Illumina, Inc., Indivumed Group, Ionpath, Inc., Lunaphore Technologies S.A., Miltenyi Biotec, Nanostring Technologies, Inc., Natera Inc., Novogene Co, Ltd., Oxford Nanopore Technologies PLC, PerkinElmer, Inc., PT Pandu Biosains, Rarecyte, Inc, Rebus Biosystems, Inc., Resolve Biosciences GmbH, S2 Genomics, Inc., Seven Bridges Genomics, Single Cell Discoveries, Single Technologies AB, Singular Genomics System, Inc., Spatial Genomics, Springer Nature, Standard BioTools Inc., Tecan Group Ltd., Ultivue, Inc., Veracyte, Inc., Veranome Biosystems, LLC, and Vizgen Corporation.

Market Segmentation & Coverage

This research report categorizes the Spatial Genomics & Transcriptomics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Consumables, Instruments, and Software.
  • Based on Technology, market is studied across Immunohistochemistry Screening, Spatial Genomics, and Spatial Transcriptomics. The Spatial Genomics is further studied across Biochemical Techniques, Fluorescence in Situ Hybridization, Genome Perturbation Tools, Massively-Parallel Sequencing, and Microscopy-Based Live DNA Imaging. The Spatial Transcriptomics is further studied across In Situ Sequencing, Microtomy Sequencing, Sequencing-Based Methods, and Transcriptome In-vivo Analysis.
  • Based on End-Use, market is studied across Academic Institutes, Diagnostic Institutes, Pharmaceutical Manufacturer, and Translational Research.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of chronic diseases and need for designing accurate and effective drugs
      • 5.1.1.2. Improving regulatory and ethical acceptance of genomics and sequencing technologies
      • 5.1.1.3. Emerging use of spatial analysis to advance precision medicine & diagnostics
    • 5.1.2. Restraints
      • 5.1.2.1. Limited awareness among healthcare professionals about genomic medicine in developing economies
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in spatial biology primarily focused on AI, 3D printing, and standardized diagnostic biomarkers
      • 5.1.3.2. Rising public and private funding for genomics & transcriptomics research
    • 5.1.4. Challenges
      • 5.1.4.1. Reimbursement inconsistency and uncertainty in gene & single-cell sequencing
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Spatial Genomics & Transcriptomics Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables
  • 6.3. Instruments
  • 6.4. Software

7. Spatial Genomics & Transcriptomics Market, by Technology

  • 7.1. Introduction
  • 7.2. Immunohistochemistry Screening
  • 7.3. Spatial Genomics
    • 7.3.1. Biochemical Techniques
    • 7.3.2. Fluorescence in Situ Hybridization
    • 7.3.3. Genome Perturbation Tools
    • 7.3.4. Massively-Parallel Sequencing
    • 7.3.5. Microscopy-Based Live DNA Imaging
  • 7.4. Spatial Transcriptomics
    • 7.4.1. In Situ Sequencing
    • 7.4.2. Microtomy Sequencing
    • 7.4.3. Sequencing-Based Methods
    • 7.4.4. Transcriptome In-vivo Analysis

8. Spatial Genomics & Transcriptomics Market, by End-Use

  • 8.1. Introduction
  • 8.2. Academic Institutes
  • 8.3. Diagnostic Institutes
  • 8.4. Pharmaceutical Manufacturer
  • 8.5. Translational Research

9. Americas Spatial Genomics & Transcriptomics Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Spatial Genomics & Transcriptomics Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Spatial Genomics & Transcriptomics Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. OmicsVeu Launches An Extensive Line Of Spatial Biology
    • 12.3.2. Bio-Rad Launches SEQuoia Express Stranded RNA Library Prep Kit at AGBT 2022
    • 12.3.3. Lexogen Introduces CORALL RNA-Seq V2 - a fast and flexible whole transcriptome RNA-Seq Library Prep Kit.
    • 12.3.4. NanoString Launches New nCounter Pro Analysis System
    • 12.3.5. Singular Genomics Partners with QIAGEN to Enable QIAseq Kits for the G4 Sequencing Platform
    • 12.3.6. Fulgent Genetics Announces Strategic Investment in Spatial Genomics
    • 12.3.7. Singular Genomics Partners with Lexogen to Enable RNA Library Prep for the G4 Sequencing Platform
    • 12.3.8. Bio-Techne and Akoya Biosciences Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution
    • 12.3.9. Andor and Akoya Biosciences to Collaborate in Spatial Omics market
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 10X Genomics, Inc.
  • 2. Akoya Biosciences, Inc.
  • 3. Arima Genomics, Inc.
  • 4. AtlasXomics Inc.
  • 5. Axcelead Drug Discovery Partners Inc.
  • 6. BGI Australia
  • 7. Bio-Techne Corporation
  • 8. BioSpyder Technologies Inc.
  • 9. Bruker Corporation
  • 10. Bucher Biotec AG
  • 11. CD Genomics
  • 12. CeGaT GmbH
  • 13. Dovetail Genomics, LLC
  • 14. Easi-Genomics
  • 15. Enzo Life Sciences, Inc.
  • 16. Eurofins Genomics
  • 17. Fulgent Genetics
  • 18. Genomic Vision SA
  • 19. Illumina, Inc.
  • 20. Indivumed Group
  • 21. Ionpath, Inc.
  • 22. Lunaphore Technologies S.A.
  • 23. Miltenyi Biotec
  • 24. Nanostring Technologies, Inc.
  • 25. Natera Inc.
  • 26. Novogene Co, Ltd.
  • 27. Oxford Nanopore Technologies PLC
  • 28. PerkinElmer, Inc.
  • 29. PT Pandu Biosains
  • 30. Rarecyte, Inc
  • 31. Rebus Biosystems, Inc.
  • 32. Resolve Biosciences GmbH
  • 33. S2 Genomics, Inc.
  • 34. Seven Bridges Genomics
  • 35. Single Cell Discoveries
  • 36. Single Technologies AB
  • 37. Singular Genomics System, Inc.
  • 38. Spatial Genomics
  • 39. Springer Nature
  • 40. Standard BioTools Inc.
  • 41. Tecan Group Ltd.
  • 42. Ultivue, Inc.
  • 43. Veracyte, Inc.
  • 44. Veranome Biosystems, LLC
  • 45. Vizgen Corporation

LIST OF FIGURES

  • FIGURE 1. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET RESEARCH PROCESS
  • FIGURE 2. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET DYNAMICS
  • TABLE 7. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY SCREENING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY BIOCHEMICAL TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY GENOME PERTURBATION TOOLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY MASSIVELY-PARALLEL SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY MICROSCOPY-BASED LIVE DNA IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY IN SITU SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY MICROTOMY SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING-BASED METHODS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TRANSCRIPTOME IN-VIVO ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DIAGNOSTIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PHARMACEUTICAL MANUFACTURER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TRANSLATIONAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 72. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 77. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 78. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 82. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 83. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 87. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 88. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 92. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 93. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 97. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 98. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 102. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 103. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 107. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 108. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 112. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 113. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 117. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 118. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 122. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 123. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 127. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 128. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 138. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 139. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 143. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 144. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 148. FINLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 149. FINLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 153. FRANCE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 154. FRANCE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 158. GERMANY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 159. GERMANY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 163. ISRAEL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 164. ISRAEL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 168. ITALY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 169. ITALY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 173. NETHERLANDS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 174. NETHERLANDS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 178. NIGERIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 179. NIGERIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 183. NORWAY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 184. NORWAY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 188. POLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 189. POLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 193. QATAR SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 194. QATAR SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 198. RUSSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 199. RUSSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 203. SAUDI ARABIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 204. SAUDI ARABIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 208. SOUTH AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 209. SOUTH AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 213. SPAIN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 214. SPAIN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 218. SWEDEN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 219. SWEDEN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 223. SWITZERLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 224. SWITZERLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 228. TURKEY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 229. TURKEY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED ARAB EMIRATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED ARAB EMIRATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 238. UNITED KINGDOM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
  • TABLE 239. UNITED KINGDOM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 240. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 241. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, FPNV POSITIONING MATRIX, 2023